Skip Navigation LinksHome > October 10, 2003 - Volume 25 - Issue 19 > New Medicines in Development for Cancer, Part 3
Text sizing:
A
A
A
Oncology Times:
doi: 10.1097/01.COT.0000291007.70576.1c
Article

New Medicines in Development for Cancer, Part 3

Free Access

This table (Parts 1 and 2 appeared in the September issues) is adapted and excerpted from the latest Pharmaceutical Research and Manufacturers of America survey of New Medicines in Development for Cancer. As of the time of the report in May, there were 395 cancer-related medicines in the pipeline, with research being conducted by 181 companies as well as the NCI. Shown for each item are the name of the product, the company/organization involved, the cancer indication, the development status, and a contact telephone number when available to request further information.

Table. No caption av...
Image Tools
Table. No caption av...
Image Tools
Table. No caption av...
Image Tools
Table. No caption av...
Image Tools
Table. No caption av...
Image Tools
Table. No caption av...
Image Tools

© 2003 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Images

Share